Are you Dr. Robins?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 65 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
7887 Almor Dr
Verona, WI 53593Phone+1 608-263-1416
Summary
- Dr. H Robins, MD is a hematologist in Verona, Wisconsin. He is currently licensed to practice medicine in Wisconsin, Florida, and Illinois. He is affiliated with University Hospital.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1979 - 1982- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1976 - 1979
Boston University School of MedicineClass of 1976
Certifications & Licensure
WI State Medical License 1977 - 2025
FL State Medical License 2021 - 2023
IL State Medical License 1988 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer Start of enrollment: 2005 Dec 20
- Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Start of enrollment: 2004 Oct 06
- A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With Bevacizumab Start of enrollment: 2012 Dec 03
Publications & Presentations
PubMed
- 18 citationsA Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive GlioblastomaDavid M. Peereboom, Xiaobu Ye, Tom Mikkelsen, Glenn J. Lesser, Frank S. Lieberman
Neurosurgery. 2021-01-13 - 207 citationsA Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer ...Paul W. Sperduto, Meihua Wang, H. Ian Robins, Michael C. Schell, Maria Werner-Wasik
International Journal of Radiation Oncology, Biology, Physics. 2013-04-01 - 55 citationsA randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: An NRG oncology RTOG group studyH. Ian Robins, Peixin Zhang, Mark R. Gilbert, Arnab Chakravarti, John de Groot
Journal of Neuro-Oncology. 2016-01-01
Grant Support
- Phase I Trial Of Intravenous Thymidine And CarboplatinNational Center For Research Resources1995
- Phase I Evaluation Of IV Melphalan And Whole Body HyperthermiaNational Center For Research Resources1995
Professional Memberships
- Member
